Axsome Therapeutics Inc is trading at $163.19 (-35.28%) in after-hours trading following a sharp drop from the regular-session close, despite no immediate company-specific earnings or FDA announcements.
- The significant decline stands out against a broadly weaker market environment, with major indices and futures trading lower as risk assets face pressure.
- While no major news has been confirmed, the magnitude of the move suggests a potential late-breaking company catalyst may still emerge.